Related Experiment Video
Updated: Jun 17, 2026

04:05
Surgical Model for Single-Staged Tissue-Engineered Urothelial Tubes in Minipigs
Published on: July 5, 2024
Next generation biodegradable ureteral stent in a yucatan pig model
Ben H Chew1, Dirk Lange, Ryan F Paterson
1Stone Centre at Vancouver General Hospital, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. ben.chew@ubc.ca
The Journal of Urology
|December 22, 2009
Summary
New biodegradable ureteral stents (Uriprene) show rapid degradation and improved biocompatibility. These advanced stents offer better kidney drainage and reduced complications compared to traditional stents.
Area of Science:
- Biomaterials Science
- Urology
- Medical Devices
Background:
- Ureteral stents are crucial for kidney drainage but cause symptoms and require removal.
- Previous biodegradable stents had issues with biocompatibility and degradation.
- First-generation biodegradable stents degraded by 10 weeks and needed a sheath for placement.
Purpose of the Study:
- To report on second and third-generation biodegradable ureteral stents (Uriprene).
- To evaluate their rapid degradation and ease of placement.
- To assess their biocompatibility and efficacy in facilitating kidney drainage.
Main Methods:
- Two groups of Yucatan pigs were stented with control biostable or second-generation Uriprene stents.
- Renal function, hydronephrosis, and stent degradation were monitored via ultrasound and urography.
- Third-generation stents were implanted in Yorkshire pigs to assess degradation and function.
Main Results:
- Second-generation Uriprene stents degraded within 10 weeks; third-generation stents degraded within 4 weeks.
- Uriprene stents showed less hydronephrosis and reduced ureteral inflammation compared to biostable stents.
- Uriprene stents demonstrated high tensile and coil strength, comparable to commercial plastic stents.
Conclusions:
- Uriprene biodegradable ureteral stents are biocompatible and ensure effective renal drainage.
- These stents significantly reduce the need for secondary removal procedures.
- They hold promise for minimizing stent-related morbidity, including infection and irritative symptoms.